Compare Health RX is an independent editorial comparison platform focused exclusively on GLP-1 telehealth providers for weight management. We are not a pharmacy, telehealth provider, or medical practice. We do not prescribe medications and we do not provide medical advice.
Our mission is to help individuals make informed decisions about GLP-1 treatment options by providing transparent, research-backed comparisons of pricing, medication types, clinician quality, and support structures.
Our editorial team includes researchers with backgrounds in health policy, consumer advocacy, and digital health journalism. We evaluate GLP-1 providers through a structured scoring framework developed in consultation with general healthcare knowledge and updated monthly based on provider changes and user feedback.
We are not clinicians and our content should not be used as medical advice. All editorial content is produced for educational purposes and to support decision-making — not to replace a consultation with a licensed healthcare provider.
Every provider listed on Compare Health RX is scored using our Editorial Evaluation Score (EES) — a 100-point framework broken into 5 weighted categories:
Speed of clinician review, licensing standards, provider oversight model, and ongoing support availability.
Clarity of pricing, absence of hidden fees, dosage upcharging practices, and whether pricing is published prominently.
Range of GLP-1 options (semaglutide, tirzepatide), oral vs injectable, brand-name availability, and compounding quality signals.
Average time from approval to delivery, shipping method, temperature control, and refund policy if not approved.
Availability of ongoing nursing/clinical support, dose adjustment processes, communication channels, and patient portal quality.
Compare Health RX earns affiliate commissions when visitors click through to a provider and make a purchase. This compensation helps fund our editorial operations. We disclose this prominently on every page of this site.
Affiliate compensation may influence which providers we choose to include on our platform, the order in which providers are presented, and promotional content shown for specific providers. However, affiliate compensation does not affect our Editorial Evaluation Scores (EES). Scores are calculated independently from commercial relationships.
Providers that do not have an active affiliate relationship with us may still appear on our comparison pages if our editorial team determines they are relevant to users. Conversely, having an affiliate relationship does not guarantee a high editorial score.
We update pricing information monthly by reviewing each provider's publicly available website. Prices can change at any time without notice. Always verify current pricing directly with the provider before making a purchase decision.
Clinical information on this site (weight loss averages, mechanism descriptions, side effect profiles) is sourced from publicly available peer-reviewed research including STEP-1 (Novo Nordisk, semaglutide) and SURMOUNT-1 (Eli Lilly, tirzepatide) clinical trials, the FDA drug database, and professional medical publications.
Important: Content on this site is for informational purposes only and is not a substitute for professional medical advice. GLP-1 medications are prescription drugs that require evaluation and approval by a licensed clinician. We strongly encourage all visitors to consult a healthcare provider before starting any prescription weight-loss treatment.
For editorial inquiries, corrections, or partnership information, contact us at hello@comparehealthrx.com
CompareHealthRX LLC
30 N Gould St, Suite R, Sheridan, WY 82801